# Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

> **NCT04347122** · PHASE4 · TERMINATED · sponsor: **University of Kansas Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Musculoskeletal Cancer
- Sarcoma,Soft Tissue

## Interventions

- **DRUG:** Tranexamic Acid (TXA)

## Key facts

- **NCT ID:** NCT04347122
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-28
- **Primary completion:** 2023-08-18
- **Final completion:** 2023-08-18
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** recruitment stalled
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04347122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04347122, "Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04347122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*